Infectious Disease Frontier

The 2026 Asia-Pacific AIDS and Co-infections Conference (APACC 2026) was successfully held in Tokyo, Japan. Focusing on cutting-edge practices and technological innovations in the prevention and control of HIV and sexually transmitted infections, the conference gathered global experts in the field to explore pathways for optimizing public health services. Our journal specially invited Professor Jason Ong from the Melbourne Sexual Health Centre in Australia for an in-depth interview.

The 11th Asia-Pacific AIDS & Co-Infections Conference (APACC 2026) was successfully convened in Tokyo, Japan. Bringing together HIV prevention and control experts from across the region, the conference focused on core regional challenges including standardized antiretroviral therapy (ART) and whole-course management for people living with HIV, serving as an exchange platform to advance the optimization of HIV diagnosis and treatment in the Asia-Pacific.

The 2026 Asia-Pacific AIDS and Co-infections Conference (APACC 2026) was successfully held in Tokyo, Japan. Focusing on core public health issues such as continuous care for people living with HIV (PLHIV) and co-infection management, the conference gathered frontline clinical researchers from multiple countries to share local prevention and control practices and research findings. Infectious Disease Frontier specially invited Dr. Rodenie Arnaiz Olete, MEARL Lead of Sustained Health Initiatives of the Philippines, and his colleague, Dr. Patrick Eustaquio, Director for Clinical Programs of SAIL Clinics in the Philippines, for an in-depth interview. Combining real-world clinical data from the Philippines, the two discussed practical challenges including factors associated with HIV care disengagements, innovative intervention models in community clinics, and integrated diagnosis and treatment of hepatitis B and HIV co-infection. Integrating research conclusions with frontline clinical practical experience, they provide localized reference ideas for low- and middle-income countries to optimize the continuum of care for PLHIV.

Editorial Note: The 2026 Asia-Pacific AIDS & Co-infections Conference (APACC 2026) was successfully held in Tokyo, Japan. Centered on the clinical hot topics of metabolic complications in people living with HIV (PLWH), the conference delivered cutting-edge insights for clinical practice across the Asia-Pacific region. During the conference, Infectious Disease Frontier conducted an exclusive interview with Dr. Hay Mar Su Lwin, Research Physician (MBBS MCTM) at the HIV Netherlands Australia Thailand Research Collaboration. Glycemic abnormality is a prevalent metabolic complication among PLWH receiving long-term antiretroviral therapy (ART), and intervention during prediabetes is a critical link in disease prevention and control. Drawing on long-term cohort studies, Dr. Lwin shared in-depth perspectives on risk factors linked to glycemic deterioration in PLWH, metabolic impacts of distinct antiretroviral regimens, and tailored clinical strategies for Asian populations. This interview integrates evidence-based data and practical clinical guidance, offering vital references for clinicians in domestic infectious disease departments to optimize glycemic screening, lifestyle intervention, and individualized selection of ART regimens.

The 11th Asia-Pacific AIDS & Co-infections Conference (APACC 2026) was successfully held in Tokyo, Japan. The prevention and control of sexually transmitted infections (STIs) has emerged as one of the most heated topics at the conference. To sort out current cutting-edge prevention and control strategies, Infectious Disease Frontier invited Professor Eric Chow from the Melbourne Sexual Health Centre, Monash University, for an exclusive in-depth interview.

The 20th European AIDS Clinical Society (EACS) Conference (EACS 2025) officially commenced on October 15, 2025, in Paris, France. Under the theme "From Science to Implementation," the conference aims to…

ntimicrobial resistance (AMR) has become a major global public health challenge. To enhance capabilities in diagnosing and treating infectious diseases and promote rational use of antimicrobial agents in China, the 11th Academic Conference of the Infectious Diseases Society of China (IDSC) under the China Medicine Education Association was recently held in Beijing. At the conference, Professor Yoshiaki Gu from the Institute of Science Tokyo (Science Tokyo) shared Japan’s experience in AMR control. Infectious Disease Frontier invited Professor Gu to provide an in-depth analysis of the evolving threat of drug-resistant pathogens in Japan, the outcomes of its National Action Plan, and innovative public education initiatives. He further explored critical future directions for antimicrobial drug development and cross-sectoral collaboration under the "One Health" strategy.

At the Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Professor Joe Jarvis from the National Institute for Health and Care Research (NIHR) shared urgent perspectives on a critically underserved area—advanced…